Abdul Mullick

Chief Executive Officer at KYOWA KIRIN CO., LTD.

Health Technology

Consumer Services

Commercial Services

Profile

Abdul Mullick is President, CEO, COO & Representative Director at Kyowa Kirin Co., Ltd. since 2026 and Director at Orchard Therapeutics Plc since 2024.
Former roles include President & Chief Executive Officer at Kyowa Kirin International Plc from 2018 to 2023, Director at Mereo BioPharma Group Plc in 2022, Head-Global Strategic Marketing at Vifor Pharma Management AG from 2014 to 2018, Senior Director-European Business Unit at Endocrine Pharmaceuticals Ltd., Senior Director-Global Brand & Diabetes at Novartis Pharma AG, Vice President, GM-Endocrinology & Cardiology at Genzyme Corp.
Education includes a doctorate from the University of Bristol.

Abdul Mullick active positions

Companies	Position	Start
ORCHARD THERAPEUTICS PLC	Director/Board Member	2024-01-23
KYOWA KIRIN CO., LTD.	Chief Executive Officer	2026-02-28

All active positions of Abdul Mullick

Former positions of Abdul Mullick

Companies	Position	End
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Chief Executive Officer	2022-12-31
MEREO BIOPHARMA GROUP PLC	Director/Board Member	2022-11-09
Vifor Pharma Management AG Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency	Corporate Officer/Principal	2018-03-31
Endocrine Pharmaceuticals Ltd. Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops hormonal drugs	Corporate Officer/Principal	-
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	-

See the detail of Abdul Mullick's experience

Training of Abdul Mullick

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Abdul Mullick's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Health Technology
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Endocrine Pharmaceuticals Ltd. Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops hormonal drugs	Commercial Services
Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals	Health Technology
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Vifor Pharma Management AG Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency	Health Technology
Mereo BioPharma Group Plc Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology